Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitors
申请人:NUVATION BIO INC.
公开号:US11332473B2
公开(公告)日:2022-05-17
This invention provides for substituted pyrazolo[3,4-d]pyrimidine compounds of the Formula (I):
as Wee1 inhibitors. The substituted pyrazolo[3,4-d]pyrimidine compounds may find use as therapeutic agents for the treatment of diseases. The substituted pyrazolo[3,4-d]pyrimidine compounds may also find particular use in oncology.